#BEGIN_DRUGCARD DB03309

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C8H17NO3S

# Chemical_IUPAC_Name:
2-(cyclohexylamino)ethane-1-sulfonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
N-Cyclohexyltaurine

# HET_ID:
NHE

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C8H17NO3S/c10-13(11,12)7-6-9-8-4-2-1-3-5-8/h8-9H,1-7H2,(H,10,11,12)

# InChI_Key:
InChIKey=MKWKNSIESPFAQN-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3309

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
207.29

# Molecular_Weight_Mono:
207.092914105

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1P7J

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.1

# Predicted_LogS:
-1.7

# Predicted_Water_Solubility:
3.97e+00 g/l

# Primary_Accession_No:
DB03309

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
66898

# PubChem_Substance_ID:
46506550

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02344

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OS(=O)(=O)CCNC1CCCCC1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
CHES

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:07 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M10456

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
P/V

# Drug_Target_1_Gene_Sequence:
>1524 bp
ATGGCAGAAGAGCAGGCACGCCATGTCAAAAACGGACTGGAATGCATCCGGGCTCTCAAG
GCCGAGCCCATCGGCTCACTGGCCATCGAGGAAGCTATGGCAGCATGGTCAGAAATATCA
GACAACCCAGGACAGGAGCGAGCCACCTGCAGGGAAGAGAAGGCAGGCAGTTCGGGTCTC
AGCAAACCATGCCTCTCAGCAATTGGATCAACTGAAGGCGGTGCACCTCGCATCCGCGGT
CAGGGACCTGGAGAGAGCGATGACGACGCTGAAACTTTGGGAATCCCCCCAAGAAATCTC
CAGGCATCAAGCACTGGGTTACAGTGTTATTATGTTTATGATCACAGCGGTGAAGCGGTT
AAGGGAATCCAAGATGCTGACTCTATCATGGTTCAATCAGGCCTTGATGGTGATAGCACC
CTCTCAGGAGGAGACAATGAATCTGAAAACAGCGATGTGGATATTGGCGAACCTGATACC
GAGGGATATGCTATCACTGACCGGGGATCTGCTCCCATCTCTATGGGGTTCAGGGCTTCT
GATGTTGAAACTGCAGAAGGAGGGGAGATCCACGAGCTCCTGAGACTCCAATCCAGAGGC
AACAACTTTCCGAAGCTTGGGAAAACTCTCAATGTTCCTCCGCCCCCGGACCCCGGTAGG
GCCAGCACTTCCGGGACACCCATTAAAAAGGGCACAGAGCGCAGATTAGCCTCATTTGGA
ACGGAGATCGCGTCTTTATTGACAGGTGGTGCAACCCAATGTGCTCGAAAGTCACCCTCG
GAACCATCAGGGCCAGGTGCACCTGCGGGGAATGTCCCCGAGTGTGTGAGCAATGCCGCA
CTGATACAGGAGTGGACACCCGAATCTGGTACCACAATCTCCCCGAGATCCCAGAATAAT
GAAGAAGGGGGAGACTATTATGATGATGAGCTGTTCTCTGATGTCCAAGATATTAAAACA
GCCTTGGCCAAAATACACGAGGATAATCAGAAGATAATCTCCAAGCTAGAATCACTGCTG
TTATTGAAGGGAGAAGTTGAGTCAATTAAGAAGCAGATCAACAGGCAAAATATCAGCATA
TCCACCCTGGAAGGACACCTCTCAAGCATCATGATCGCCATTCCTGGACTTGGGAAGGAT
CCCAACGACCCCACTGCAGATGTCGAAATCAATCCCGACTTGAAACCCATCATAGGCAGA
GATTCAGGCCGAGCACTGGCCGAAGTTCTCAAGAAACCCGTTGCCAGCCGACAACTCCAA
GGAATGACAAATGGACGGACCAGTTCCAGAGGACAGCTGCTGAAGGAATTTCAGCTAAAG
CCGATCGGGAAAAAGATGAGCTCAGCCGTCGGGTTTGTTCCTGACACCGGCCCTGCATCA
CGCAGTGTAATCCGCTCCATTATAAAATCCAGCCGGCTAGAGGAGGATCGGAAGCGTTAC
CTGATGACTCTCCTTGATGATATCAAAGGAGCCAATGATCTTGCCAAGTTCCACCAGATG
CTGATGAAGATAATAATGAAGTAG

# Drug_Target_1_General_Function:
Involved in RNA binding

# Drug_Target_1_General_References:
3882996	Bellini WJ, Englund G, Rozenblatt S, Arnheiter H, Richardson CD: Measles virus P gene codes for two proteins. J Virol. 1985 Mar;53(3):908-19.
6547185	Bellini WJ, Englund G, Richardson CD, Rozenblatt S: Positive identification of a measles virus cDNA clone encoding a region of the phosphoprotein. J Virol. 1984 Jun;50(3):939-42.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
5214

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
54057

# Drug_Target_1_Name:
Phosphoprotein

# Drug_Target_1_Number_of_Residues:
507

# Drug_Target_1_PDB_ID:
1T6O

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01647	Morbilli_P
PF08380	Viral-P_C

# Drug_Target_1_Protein_Sequence:
>Phosphoprotein
MAEEQARHVKNGLECIRALKAEPIGSLAIEEAMAAWSEISDNPGQERATCREEKAGSSGL
SKPCLSAIGSTEGGAPRIRGQGPGESDDDAETLGIPPRNLQASSTGLQCYYVYDHSGEAV
KGIQDADSIMVQSGLDGDSTLSGGDNESENSDVDIGEPDTEGYAITDRGSAPISMGFRAS
DVETAEGGEIHELLRLQSRGNNFPKLGKTLNVPPPPDPGRASTSGTPIKKGTERRLASFG
TEIASLLTGGATQCARKSPSEPSGPGAPAGNVPECVSNAALIQEWTPESGTTISPRSQNN
EEGGDYYDDELFSDVQDIKTALAKIHEDNQKIISKLESLLLLKGEVESIKKQINRQNISI
STLEGHLSSIMIAIPGLGKDPNDPTADVEINPDLKPIIGRDSGRALAEVLKKPVASRQLQ
GMTNGRTSSRGQLLKEFQLKPIGKKMSSAVGFVPDTGPASRSVIRSIIKSSRLEEDRKRY
LMTLLDDIKGANDLAKFHQMLMKIIMK

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Essential component of the RNA polymerase and the nascent chain assembly complex. Also required during RNA synthesis

# Drug_Target_1_SwissProt_ID:
P03422

# Drug_Target_1_SwissProt_Name:
PHOSP_MEASE

# Drug_Target_1_Synonyms:
Protein P

# Drug_Target_1_Theoretical_pI:
4.87

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Periplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
U75413

# Drug_Target_2_GenBank_ID_Protein:
1654415

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
nirS

# Drug_Target_2_Gene_Sequence:
>1791 bp
ATGAGACAAAGGACTCCATTCGCCAGACCCGGCCTCCTGGCCTCGGCAGCCCTGGCCCTT
GTCCTTGGACCGCTTGCGGCCGCGGCACAGGAACAGGTCGCCCCGCCAAAGGATCCAGCC
GCCGCGCTGGAGGACCACAAGACGCGCACCGACAATCGCTATGAGCCCTCGCTGGACAAC
CTTGCGCAGCAGGATGTCGCGGCTCCCGGGGCCCCCGAGGGTGTCACGGCCCTGTCCGAT
GCCCAATACAACGAGGCCAACAAGATCTATTTCGAACGCTGCGCCGGCTGCCACGGCGTG
TTGCGCAAAGGCGCGACCGGCAAGGCGCTGACCCCTGACCTGACCCGCGATCTGGGCTTT
GACTACCTGCAAAGCTTCATCACCTACGCCTCGCCGGCGGGGATGCCGAACTGGGGCACC
TCGGGCGAGTTGTCGGCCGAGCAGGTCGACCTGATGGCCAACTACCTGCTTCTGGACCCG
GCCGCGCCGCCGGAATTCGGCATGAAGGAGATGCGCGAATCCTGGAAGGTGCATGTCGCG
CCGGAAGACCGGCCGACCCAGCAGGAAAACGACTGGGATCTGGAAAACCTGTTCAGCGTC
ACCCTGCGCGACGCCGGCCAGATCGCGCTGATCGACGGCACCACCTATGAGATCAAGTCG
GTCCTCGACACCGGCTATGCGGTCCATATCAGCCGGCTGTCCGCATCGGGCCGCTACCTG
TTCGTGATCGGCCGCGACGGCAAGGTCAACATGATCGACCTGTGGATGAAGGAGCCCACC
ACCGTTGCCGAGATCAAGATCGGCTCGGAGGCGCGTTCCATCGAGACCTCGAAGATGGAG
GGCTGGGAGGACAAATACGCCATCGCCGGGGCCTATTGGCCGCCGCAATACGTCATCATG
GACGGCGAGACGCTGGAGCCGAAAAAGATCCAGTCCACGCGCGGCATGACCTATGACGAG
CAGGAATATCACCCCGAGCCGCGCGTCGCCGCGATCCTCGCCAGCCATTACCGGCCCGAG
TTCATCGTGAACGTCAAGGAAACGGGCAAGATCCTGCTGGTCGACTATACCGACCTCGAC
AACCTCAAGACCACCGAGATCAGCGCCGAACGCTTCCTGCACGACGGCGGCCTGGACGGC
TCGCACCGCTATTTCATCACCGCGGCGAACGCCCGCAACAAGCTGGTGGTGATCGACACC
AAGGAAGGCAAGCTGGTCGCGATCGAGGATACCGGCGGCCAGACCCCGCATCCGGGCCGC
GGCGCGAACTTCGTCCACCCGACCTTCGGGCCGGTCTGGGCGACCTCGCATATGGGCGAC
GATTCGGTGGCGCTGATCGGCACCGATCCCGAGGGCCATCCCGACAATGCCTGGAAGATC
CTCGACAGCTTCCCGGCGTTGGGGGGCGGCTCGCTGTTCATCAAGACGCACCCGAACTCG
CAATATCTCTATGTCGATGCGACCCTGAACCCCGAGGCCGAGATTTCCGGCTCGGTCGCG
GTGTTCGACATCAAGGCGATGACGGGCGACGGTTCGGACCCCGAGTTCAAGACCCTGCCC
ATCGCCGAATGGGCCGGCATCACCGAAGGCCAGCCCCGCGTCGTGCAGGGCGAGTTCAAC
AAGGACGGCACCGAGGTCTGGTTCAGCGTCTGGAACGGCAAGGACCAGGAATCGGCGCTG
GTCGTGGTGGACGACAAGACGCTGGAACTTAAGCACGTCATCAAGGACGAGCGGCTGGTG
ACGCCCACCGGCAAGTTCAACGTCTACAACACCATGACCGACACCTATTGA

# Drug_Target_2_General_Function:
Energy production and conversion

# Drug_Target_2_General_References:
10708389	Saunders NF, Ferguson SJ, Baker SC: Transcriptional analysis of the nirS gene, encoding cytochrome cd1 nitrite reductase, of Paracoccus pantotrophus LMD 92.63. Microbiology. 2000 Feb;146 ( Pt 2):509-16.
10827177	Jafferji A, Allen JW, Ferguson SJ, Fulop V: X-ray crystallographic study of cyanide binding provides insights into the structure-function relationship for cytochrome cd1 nitrite reductase from Paracoccus pantotrophus. J Biol Chem. 2000 Aug 18;275(33):25089-94.
10998233	Sjogren T, Svensson-Ek M, Hajdu J, Brzezinski P: Proton-coupled structural changes upon binding of carbon monoxide to cytochrome cd1: a combined flash photolysis and X-ray crystallography study. Biochemistry. 2000 Sep 12;39(36):10967-74.
11237728	Gordon EH, Steensma E, Ferguson SJ: The cytochrome c domain of dimeric cytochrome cd(1) of Paracoccus pantotrophus can be produced at high levels as a monomeric holoprotein using an improved c-type cytochrome expression system in Escherichia coli. Biochem Biophys Res Commun. 2001 Mar 2;281(3):788-94.
11278884	Sjogren T, Hajdu J: Structure of the bound dioxygen species in the cytochrome oxidase reaction of cytochrome cd1 nitrite reductase. J Biol Chem. 2001 Apr 20;276(16):13072-6. Epub 2001 Jan 26.
11373294	Sjogren T, Hajdu J: The Structure of an alternative form of Paracoccus pantotrophus cytochrome cd(1) nitrite reductase. J Biol Chem. 2001 Aug 3;276(31):29450-5. Epub 2001 May 23.
7736589	Fulop V, Moir JW, Ferguson SJ, Hajdu J: The anatomy of a bifunctional enzyme: structural basis for reduction of oxygen to water and synthesis of nitric oxide by cytochrome cd1. Cell. 1995 May 5;81(3):369-77.
9199411	Baker SC, Saunders NF, Willis AC, Ferguson SJ, Hajdu J, Fulop V: Cytochrome cd1 structure: unusual haem environments in a nitrite reductase and analysis of factors contributing to beta-propeller folds. J Mol Biol. 1997 Jun 13;269(3):440-55.
9311786	Williams PA, Fulop V, Garman EF, Saunders NF, Ferguson SJ, Hajdu J: Haem-ligand switching during catalysis in crystals of a nitrogen-cycle enzyme. Nature. 1997 Sep 25;389(6649):406-12.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3284

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
65384

# Drug_Target_2_Name:
Nitrite reductase

# Drug_Target_2_Number_of_Residues:
596

# Drug_Target_2_PDB_ID:
1HCM

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00034	Cytochrom_C
PF02239	Cytochrom_D1

# Drug_Target_2_Protein_Sequence:
>Nitrite reductase precursor
MRQRTPFARPGLLASAALALVLGPLAASAQEQVAPPKDPAAALEDHKTRTDNRYEPSLDN
LAQQDVAAPGAPEGVSALSDAQYNEANKIYFERCAGCHGVLRKGATGKALTPDLTRDLGF
DYLQSFITYGSPAGMPNWGTSGELSAEQVDLMANYLLLDPAAPPEFGMKEMRESWKVHVA
PEDRPTQQENDWDLENLFSVTLRDAGQIALIDGATYEIKSVLDTGYAVHISRLSASGRYL
FVIGRDGKVNMIDLWMKEPTTVAEIKIGSEARSIETSKMEGWEDKYAIAGAYWPPQYVIM
DGETLEPKKIQSTRGMTYDEQEYHPEPRVAAILASHYRPEFIVNVKETGKILLVDYTDLD
NLKTTEISAERFLHDGGLDGSHRYFITAANARNKLVVIDTKEGKLVAIEDTGGQTPHPGR
GANFVHPTFGPVWATSHMGDDSVALIGTDPEGHPDNAWKILDSFPALGGGSLFIKTHPNS
QYLYVDATLNPEAEISGSVAVFDIKAMTGDGSDPEFKTLPIAEWAGITEGQPRVVQGEFN
KDGTEVWFSVWNGKDQESALVVVDDKTLELKHVIKDERLVTPTGKFNVYNTMTDTY

# Drug_Target_2_Reaction:
nitric oxide + H2O + ferricytochrome c = nitrite + ferrocytochrome c + 2 H+

# Drug_Target_2_Signals:
1-29

# Drug_Target_2_Specific_Function:
Nitric oxide + H(2)O + ferricytochrome c = nitrite + ferrocytochrome c + 2 H(+)

# Drug_Target_2_SwissProt_ID:
P72181

# Drug_Target_2_SwissProt_Name:
NIRS_PARPN

# Drug_Target_2_Synonyms:
Cytochrome cd1
Cytochrome oxidase
EC 1.7.2.1
EC 1.7.99.1
Hydroxylamine reductase
Nitrite reductase precursor

# Drug_Target_2_Theoretical_pI:
4.59

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
Not Available

# Drug_Target_3_GenBank_ID_Protein:
Not Available

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
EN2

# Drug_Target_3_Gene_Sequence:
Not Available

# Drug_Target_3_General_Function:
Not Available

# Drug_Target_3_General_References:
Not Available

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
6994

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
Not Available

# Drug_Target_3_Name:
Homeobox protein engrailed-2

# Drug_Target_3_Number_of_Residues:
0

# Drug_Target_3_PDB_ID:
Not Available

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
Not Available

# Drug_Target_3_Protein_Sequence:
Not Available

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
Not Available

# Drug_Target_3_Specific_Function:
Not Available

# Drug_Target_3_SwissProt_ID:
P19622

# Drug_Target_3_SwissProt_Name:
HME2_HUMAN

# Drug_Target_3_Synonyms:
Not Available

# Drug_Target_3_Theoretical_pI:
Not Available

# Drug_Target_3_Transmembrane_Regions:
Not Available

# Drug_Target_4_Cellular_Location:
Cytoplasmic

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
U38241

# Drug_Target_4_GenBank_ID_Protein:
1079663

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
rph

# Drug_Target_4_Gene_Sequence:
>720 bp
TCATTCGGCCAGCGCGGCGCGCTGAGTTCGAACAAGCTCCTGCATGCCCTGCTGGGCCAG
TTCGAGCATGGCGTTCAGCTCGGCGGGACGGAACGGCGCGCCTTCGGCGGTTCCCTGCAC
CTCGATGAACCGCCGGCAATCGGTCATCACTACGTTCAGGTCGGATTCCGCGGCGGAATC
CTCCAGGTAGTCCAGGTCGAGGACCGGCACCCCCTGGTAGATGCCCACGGAAACGGCGGC
GACTATTTGCTTCAGCGGATTGCCCTTGAGCGCGACACGCTTCTTCAGCACCGCCAGGGC
GTCGATCAGCGACACGGTGGCGCCGGTGATTGAGGCGGTGCGGGTGCCGCCGTCGGTCTG
GATCACGTCGCAGTCGATGTACAGGGTGTTCTCGCCGAGCTTGCTGAGGTCCAGCGCCGC
TCGCAGGGAGCGGTCGATCAGGCGCTGGATCTCCAGGGTACGACCGCCCTGCTTGCCGCG
GCTGGCCTCGCGCTGGTTACGCTCGCCCGTGGAGCGCCGCAGCATGCCGTACTCGGCGGT
CAACCAACCCTGGCCCTGGCCCTTGAGGAAGCGCGGCACCCCGGACTCGGCGCTGACGGT
GCAGATCACCTTGGTATCGCCGAACTCGACCAGCACCGAACCTTCTGCGTGCTTGGTGTA
ATGGCGGGTGATGCGGATCGGGCGCAGCTGGTCGGCGGCACGGCCACTGGGACGATTCAT

# Drug_Target_4_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_4_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.
8824606	MacGregor CH, Arora SK, Hager PW, Dail MB, Phibbs PV Jr: The nucleotide sequence of the Pseudomonas aeruginosa pyrE-crc-rph region and the purification of the crc gene product. J Bacteriol. 1996 Oct;178(19):5627-35.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
3497

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
25655

# Drug_Target_4_Name:
Ribonuclease PH

# Drug_Target_4_Number_of_Residues:
239

# Drug_Target_4_PDB_ID:
1R6M

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF01138	RNase_PH
PF03725	RNase_PH_C

# Drug_Target_4_Protein_Sequence:
>Ribonuclease PH
MNRPSGRAADQLRPIRITRHYTKHAEGSVLVEFGDTKVICTVSAESGVPRFLKGQGQGWL
TAEYGMLPRSTGERNQREASRGKQGGRTLEIQRLIGRSLRAALDLSKLGENTLYIDCDVI
QADGGTRTASITGATVALIDALAVLKKRGALKGNPLKQMVAAVSVGIYQGVPVLDLDYLE
DSAAETDLNVVMTDAGGFIEVQGTAEGAPFRPAELNAMLELAQQGMQELFELQRAALAE

# Drug_Target_4_Reaction:
tRNAn+1 + phosphate = tRNAn + a nucleoside diphosphate

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Phosphorolytic exoribonuclease that removes nucleotide residues following the -CCA terminus of tRNA and adds nucleotides to the ends of RNA molecules by using nucleoside diphosphates as substrates

# Drug_Target_4_SwissProt_ID:
P50597

# Drug_Target_4_SwissProt_Name:
RNPH_PSEAE

# Drug_Target_4_Synonyms:
EC 2.7.7.56
RNase PH
tRNA nucleotidyltransferase

# Drug_Target_4_Theoretical_pI:
5.89

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
Not Available

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
Not Available

# Drug_Target_5_Gene_Sequence:
Not Available

# Drug_Target_5_General_Function:
Not Available

# Drug_Target_5_General_References:
10329150	Yang F, Bewley CA, Louis JM, Gustafson KR, Boyd MR, Gronenborn AM, Clore GM, Wlodawer A: Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping. J Mol Biol. 1999 May 7;288(3):403-12.
9210678	Boyd MR, Gustafson KR, McMahon JB, Shoemaker RH, O'Keefe BR, Mori T, Gulakowski RJ, Wu L, Rivera MI, Laurencot CM, Currens MJ, Cardellina JH 2nd, Buckheit RW Jr, Nara PL, Pannell LK, Sowder RC 2nd, Henderson LE: Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob Agents Chemother. 1997 Jul;41(7):1521-30.
9299483	Gustafson KR, Sowder RC 2nd, Henderson LE, Cardellina JH 2nd, McMahon JB, Rajamani U, Pannell LK, Boyd MR: Isolation, primary sequence determination, and disulfide bond structure of cyanovirin-N, an anti-HIV (human immunodeficiency virus) protein from the cyanobacterium Nostoc ellipsosporum. Biochem Biophys Res Commun. 1997 Sep 8;238(1):223-8.
9665171	Bewley CA, Gustafson KR, Boyd MR, Covell DG, Bax A, Clore GM, Gronenborn AM: Solution structure of cyanovirin-N, a potent HIV-inactivating protein. Nat Struct Biol. 1998 Jul;5(7):571-8.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
3444

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
11013

# Drug_Target_5_Name:
Cyanovirin-N

# Drug_Target_5_Number_of_Residues:
101

# Drug_Target_5_PDB_ID:
1M5M

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF08881	CNVH

# Drug_Target_5_Protein_Sequence:
>Cyanovirin-N
LGKFSQTCYNSAIQGSVLTSTCERTNGGYNTSSIDLNSVIENVDGSLKWQPSNFIETCRN
TQLAGSSELAAECKTRAQQFVSTKINLDDHIANIDGTLKYE

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Unknown

# Drug_Target_5_SwissProt_ID:
P81180

# Drug_Target_5_SwissProt_Name:
CVN_NOSEL

# Drug_Target_5_Synonyms:
CV-N

# Drug_Target_5_Theoretical_pI:
4.69

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Cytoplasm

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
SULT2B1

# Drug_Target_6_GenBank_ID_Gene:
U92314

# Drug_Target_6_GenBank_ID_Protein:
1923291

# Drug_Target_6_GeneCard_ID:
SULT2B1

# Drug_Target_6_Gene_Name:
SULT2B1

# Drug_Target_6_Gene_Sequence:
>1053 bp
ATGGCGTCTCCCCCACCTTTCCACAGCCAGAAGTTGCCAGGTGAATACTTCCGGTACAAG
GGCGTCCCCTTCCCCGTCGGCCTGTACTCGCTCGAGAGCATCAGCTTGGCGGAGAACACC
CAAGATGTGCGGGACGACGACATCTTTATCATCACCTACCCCAAGTCAGGCACGACCTGG
ATGATCGAGATCATCTGCTTAATCCTGAAGGAAGGGGATCCATCCTGGATCCGCTCCGTG
CCCATCTGGGAGCGGGCACCCTGGTGTGAGACCATTGTGGGTGCTTTCAGCCTCCCGGAC
CAGTACAGCCCCCGCCTCATGAGCTCCCATCTTCCCATCCAGATCTTCACCAAGGCCTTC
TTCAGCTCCAAGGCCAAGGTGATCTACATGGGCCGCAACCCCCGGGACGTTGTGGTCTCC
CTCTATCATTACTCCAAGATCGCCGGGCAGTTAAAGGACCCGGGCACACCCGACCAGTTC
CTGAGGGACTTCCTCAAAGGCGAAGTGCAGTTTGGCTCCTGGTTCGACCACATTAAGGGC
TGGCTTCGGATGAAGGGCAAAGACAACTTCCTATTTATCACCTACGAGGAGCTGCAGCAG
GACTTACAGGGCTCCGTGGAGCGCATCTGTGGGTTCCTGGGCCGTCCGCTGGGCAAGGAG
GCACTGGGCTCCGTCGTGGCACACTCAACCTTCAGCGCCATGAAGGCCAACACCATGTCC
AACTACACGCTGCTGCCTCCCAGCCTGCTGGACCACCGTCGCGGGGCCTTCCTCCGGAAA
GGGGTCTGCGGCGACTGGAAGAACCACTTCACGGTGGCCCAGAGCGAAGCCTTCGATCGT
GCCTACCGCAAGCAGATGCGGGGGATGCCGACCTTCCCCTGGGATGAAGACCCGGAGGAG
GATGGCAGCCCAGATCCTGAGCCCAGCCCTGAGCCTGAGCCCAAGCCCAGCCTTGAGCCC
AACACCAGCCTGGAGCGTGAGCCCAGACCCAACTCCAGCCCCAACCCCAGCCCCGGCCAG
GCCTCTGAGACCCCGCACCCACGACCCTCATAA

# Drug_Target_6_General_Function:
Involved in sulfotransferase activity

# Drug_Target_6_General_References:
12145317	Fuda H, Lee YC, Shimizu C, Javitt NB, Strott CA: Mutational analysis of human hydroxysteroid sulfotransferase SULT2B1 isoforms reveals that exon 1B of the SULT2B1 gene produces cholesterol sulfotransferase, whereas exon 1A yields pregnenolone sulfotransferase. J Biol Chem. 2002 Sep 27;277(39):36161-6. Epub 2002 Jul 26.
12923182	Lee KA, Fuda H, Lee YC, Negishi M, Strott CA, Pedersen LC: Crystal structure of human cholesterol sulfotransferase (SULT2B1b) in the presence of pregnenolone and 3'-phosphoadenosine 5'-phosphate. Rationale for specificity differences between prototypical SULT2A1 and the SULT2BG1 isoforms. J Biol Chem. 2003 Nov 7;278(45):44593-9. Epub 2003 Aug 14.
9799594	Her C, Wood TC, Eichler EE, Mohrenweiser HW, Ramagli LS, Siciliano MJ, Weinshilboum RM: Human hydroxysteroid sulfotransferase SULT2B1: two enzymes encoded by a single chromosome 19 gene. Genomics. 1998 Nov 1;53(3):284-95.

# Drug_Target_6_HGNC_ID:
HGNC:11459

# Drug_Target_6_HPRD_ID:
04991

# Drug_Target_6_ID:
2325

# Drug_Target_6_Locus:
19q13.3

# Drug_Target_6_Molecular_Weight:
41308

# Drug_Target_6_Name:
Sulfotransferase family cytosolic 2B member 1

# Drug_Target_6_Number_of_Residues:
365

# Drug_Target_6_PDB_ID:
1Q1Q

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF00685	Sulfotransfer_1

# Drug_Target_6_Protein_Sequence:
>Sulfotransferase family cytosolic 2B member 1
MDGPAEPQIPGLWDTYEDDISEISQKLPGEYFRYKGVPFPVGLYSLESISLAENTQDVRD
DDIFIITYPKSGTTWMIEIICLILKEGDPSWIRSVPIWERAPWCETIVGAFSLPDQYSPR
LMSSHLPIQIFTKAFFSSKAKVIYMGRNPRDVVVSLYHYSKIAGQLKDPGTPDQFLRDFL
KGEVQFGSWFDHIKGWLRMKGKDNFLFITYEELQQDLQGSVERICGFLGRPLGKEALGSV
VAHSTFSAMKANTMSNYTLLPPSLLDHRRGAFLRKGVCGDWKNHFTVAQSEAFDRAYRKQ
MRGMPTFPWDEDPEEDGSPDPEPSPEPEPKPSLEPNTSLEREPRPNSSPSPSPGQASETP
HPRPS

# Drug_Target_6_Reaction:
3'-phosphoadenylyl sulfate + an alcohol = adenosine 3',5'-bisphosphate + an alkyl sulfate

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Catalyzes the sulfate conjugation of many hormones, neurotransmitters, drugs and xenobiotic compounds. Sulfonation increases the water solubility of most compounds, and therefore their renal excretion, but it can also result in bioactivation to form active metabolites. Sulfates hydroxysteroids like DHEA. Isoform 1 preferentially sulfonates cholesterol, and isoform 2 avidly sulfonates pregnenolone but not cholesterol

# Drug_Target_6_SwissProt_ID:
O00204

# Drug_Target_6_SwissProt_Name:
ST2B1_HUMAN

# Drug_Target_6_Synonyms:
Alcohol sulfotransferase
EC 2.8.2.2
Hydroxysteroid sulfotransferase 2
Sulfotransferase 2B1

# Drug_Target_6_Theoretical_pI:
5.05

# Drug_Target_6_Transmembrane_Regions:
None

#END_DRUGCARD DB03309
